Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 45

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis

Picco, Louisa, Lam, Tina, Haines, Sarah, Nielsen, Suzanne·2021·Drug and Alcohol Dependence
DOI 10.1016/j.drugalcdep.2021.109090
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2021.109090

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 71

  1. Allen, 2019, Substance use stigma, primary care, and the New York state prescription drug monitoring program, Behav. Med., 1
  2. Arnold, 2006, Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties, Am. J. Med., 119, 292, 10.1016/j.amjmed.2005.09.019 · DOI
  3. Baehren, 2010, A statewide prescription monitoring program affects emergency department prescribing behaviors, Ann. Emerg. Med., 56, 19, 10.1016/j.annemergmed.2009.12.011 · DOI · Paper page
  4. Barrett, 2005, Physician perspectives on a pilot prescription monitoring program, J. Pain Palliat. Care Pharmacother., 19, 5, 10.1080/J354v19n03_03 · DOI
  5. Berterame, 2016, Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study, Lancet, 387, 1644, 10.1016/S0140-6736(16)00161-6 · DOI · Paper page
  6. Bialas, 2020, Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks, Eur. J. Pain, 24, 265, 10.1002/ejp.1496 · DOI
  7. Carr, 2016, Patients with pain need less stigma, not more, Pain Med., 17, 1391, 10.1093/pm/pnw158 · doi:10.1093/pm/pnw158
  8. Covidence systematic review software, 2019. Veritas Health Innovation, Melbourne, Australia.
  9. Delcher, 2020, Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019), Curr. Opin. Psychiatry, 33, 326, 10.1097/YCO.0000000000000608 · DOI
  10. Demidenko, 2017, Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users, Gen. Hosp. Psychiatry, 47, 29, 10.1016/j.genhosppsych.2017.04.011 · DOI
  11. Deyo, 2018, Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and nonusers, J. Pain, 19, 166, 10.1016/j.jpain.2017.10.001 · DOI
  12. Dickson-Gomez, 2021, Effects of implementation and enforcement differences in prescription drug monitoring programs in 3 states: connecticut, kentucky, and wisconsin, Subst. Abuse: Res. Treat., 15
  13. Doyle, 2017, Research to support optimization of prescription drug monitoring programs, Pharmacoepidemiol. Drug Saf., 26, 1425, 10.1002/pds.4300 · DOI
  14. Feldman, 2011, Awareness and utilization of a prescription monitoring program among physicians, J. Pain Palliat. Care Pharmacother., 25, 313, 10.3109/15360288.2011.606292 · DOI
  15. Fink, 2018, Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review, Ann. Intern. Med., 168, 783, 10.7326/M17-3074 · DOI · Paper page
  16. Finley, 2018, Implementing prescription drug monitoring and other clinical decision support for opioid risk mitigation in a military health care setting: a qualitative feasibility study, J. Am. Med. Inform. Assoc.: JAMIA, 515, 10.1093/jamia/ocx075 · DOI
  17. Finley, 2017, Evaluating the impact of prescription drug monitoring program implementation: a scoping review, BMC Health Serv. Res., 17, 420, 10.1186/s12913-017-2354-5 · DOI
  18. Freeman, 2004, Drug diverting patients & prescription monitoring--both sides of the debate, Iowa Med., 94, 10
  19. Gershman, 2014, Evaluation of Florida physicians’ knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool, Pain Med., 15, 2013, 10.1111/pme.12476 · doi:10.1111/pme.12476
  20. Goodin, 2021, Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: a survey study, Medicine, 100, 24268, 10.1097/MD.0000000000024268 · DOI
  21. Green, 2012, How does use of a prescription monitoring program change medical practice?, Pain Med., 13, 1314, 10.1111/j.1526-4637.2012.01452.x · DOI
  22. Green, 2013, How does use of a prescription monitoring program change pharmacy practice?, J. Am. Pharm. Assoc., 53, 273, 10.1331/JAPhA.2013.12094 · DOI
  23. Grover, 2012, How do emergency physicians interpret prescription narcotic history when assessing patients presenting to the emergency department with pain?, Permanente J., 16, 32, 10.7812/TPP/12-038 · DOI
  24. Hagemeier, 2018, Interprofessional prescription opioid abuse communication among prescribers and pharmacists: a qualitative analysis, Subst. Abuse, 39, 89, 10.1080/08897077.2017.1365803 · DOI
  25. Hagemeier, 2018, Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life, Am. J. Manag. Care, 24, S200
  26. Hernandez-Meier, 2017, The use of a statewide prescription drug monitoring program by emergency department physicians, Wisconsin Med. J., 116, 64
  27. Higgins, 2003, Measuring inconsistency in meta-analyses, Bmj, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  28. Hildebran, 2014, How clinicians use prescription drug monitoring programs: a qualitative inquiry, Pain Med., 15, 1179, 10.1111/pme.12469 · DOI · Paper page
  29. Hildebran, 2016, Clinical styles and practice policies: influence on communication with patients regarding worrisome prescription drug monitoring program data, Pain Med., 17, 2061, 10.1093/pm/pnw019 · DOI · Paper page
  30. Holmgren, 2020, A history of prescription drug monitoring programs in the United States: political appeal and public health efficacy, Am. J. Public Health, 110, 1191, 10.2105/AJPH.2020.305696 · doi:10.2105/ajph.2020.305696
  31. Hussain, 2019, Improving the design of California’s prescription drug monitoring program, JAMIA Open, 2, 160, 10.1093/jamiaopen/ooy064 · DOI
  32. Irvine, 2014, Who uses a prescription drug monitoring program and how? Insights from a statewide survey of oregon clinicians, J. Pain, 15, 747, 10.1016/j.jpain.2014.04.003 · DOI
  33. Islam, 2014, An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions, BMC Pharmacol. Toxicol., 15, 46, 10.1186/2050-6511-15-46 · DOI
  34. James, 2019, Mortality after discontinuation of primary care-based chronic opioid therapy for pain: a retrospective cohort study, J. Gen. Intern. Med., 34, 2749, 10.1007/s11606-019-05301-2 · DOI
  35. Kovitwanichkanont, 2018, Prescription opioid misuse and public health approach in Australia, Subst. Use Misuse, 53, 200, 10.1080/10826084.2017.1305415 · DOI
  36. Lee, 2020, Educating patients regarding pain management and safe opioid use after surgery: a narrative review, Anesth. Analg., 130, 574, 10.1213/ANE.0000000000004436 · DOI
  37. Leichtling, 2019, Physician responses to enhanced prescription drug monitoring program profiles, Pain Med.
  38. Leichtling, 2017, Clinicians’ use of prescription drug monitoring programs in clinical practice and decision-making, Pain Med., 18, 1063, 10.1093/pm/pnw251 · DOI
  39. LeMire, 2012, Advanced practice nurses’ use of prescription drug monitoring program information, J. Nurse Pract., 8, 383, 10.1016/j.nurpra.2012.02.016 · doi:10.1016/j.nurpra.2012.02.016
  40. Lin, 2017, Physician attitudes and experiences with Maryland’s prescription drug monitoring program (PDMP), Addiction, 112, 311, 10.1111/add.13620 · DOI
  41. McAllister, 2015, Impact of prescription drug-monitoring program on controlled substance prescribing in the ED, Am. J. Emerg. Med., 33, 781, 10.1016/j.ajem.2015.03.036 · DOI
  42. McCauley, 2019, Prescription drug monitoring program use: national dental PBRN results, JDR Clin. Transl. Res., 4, 178
  43. McCauley, 2018, Opioid prescribing and risk mitigation implementation in the management of acute pain: results from the national dental practice-based research network, J. Am. Dent. Assoc., 149, 353, 10.1016/j.adaj.2017.11.031 · DOI
  44. McCauley, 2016, Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention, Subst. Abuse, 37, 9, 10.1080/08897077.2015.1127870 · DOI
  45. McDonald, 2019, An experimental test of the effectiveness of unsolicited reporting by a prescription drug monitoring program in reducing inappropriate acquisition of opioids, Pain Med., 20, 944, 10.1093/pm/pny095 · doi:10.1093/pm/pny095
  46. McGee, 2015, Treatment agreements, informed consent, and the role of state medical boards in opioid prescribing, Pain Med., 16, 25, 10.1111/pme.12580 · doi:10.1111/pme.12580
  47. Moher, 2009, Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement, Int. J. Surg., 8
  48. National Health and Medical Research Council (NHMRC), 2009, NHMRC additional levels of evidence and grades for recommendations for developers of guidelines, Commonwealth Aust., 1
  49. Norwood, 2016, Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: improving clinical decision-making and supporting a pharmacist’s professional judgment, Res. Soc. Adm. Pharm., 12, 257, 10.1016/j.sapharm.2015.05.008 · doi:10.1016/j.sapharm.2015.05.008
  50. Oliva, 2020, Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation, BMJ, 368, 283, 10.1136/bmj.m283 · DOI · Paper page
  51. Ovadia, 2020, Changes in opioid prescribing patterns: a survey of the Florida society of plastic surgeons, Ann. Plast. Surg., 85, e54, 10.1097/SAP.0000000000002318 · DOI
  52. Perrone, 2012, Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012, J. Med. Toxicol., 8, 341, 10.1007/s13181-012-0250-2 · DOI
  53. Pett, 2020, Prescription drug monitoring program use and utility by Washington State pharmacists: a mixed-methods study, J. Am. Pharm. Assoc.: JAPhA, 60, 57, 10.1016/j.japh.2019.09.016 · DOI
  54. Ponnapalli, 2018, Systematic literature review of prescription drug monitoring programs, AMIA Annu. Symp. Proc., 2018, 1478
  55. Puac-Polanco, 2020, Prescription drug monitoring programs and prescription opioid-related outcomes in the United States, Epidemiol. Rev., 42, 134, 10.1093/epirev/mxaa002 · DOI
  56. Radomski, 2018, Physicians’ perspectives regarding prescription drug monitoring program use within the department of Veterans affairs: a multi-state qualitative study, J. Gen. Intern. Med., 33, 1253, 10.1007/s11606-018-4374-1 · DOI
  57. Reisman, 2009, Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy, Subst. Abuse: Res. Treat., 3
  58. Rhodes, 2019, The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review, BMC Health Serv. Res., 19, 784, 10.1186/s12913-019-4642-8 · DOI · Paper page
  59. Rickles, 2021, The use of an integrated opioid and medical marijuana prescription drug monitoring program, J. Am. Pharm. Assoc. JAPhA, 61, 408, 10.1016/j.japh.2021.02.020 · DOI
  60. Rittenhouse, 2015, Utilization of the arkansas prescription monitoring program to combat prescription drug abuse, Prev. Med. Rep., 2, 524, 10.1016/j.pmedr.2015.06.006 · doi:10.1016/j.pmedr.2015.06.006
  61. Rutkow, 2015, Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access, Health Affairs, 34, 484, 10.1377/hlthaff.2014.1085 · DOI
  62. Shonesy, 2019, Screening, brief intervention, and referral to treatment in a retail pharmacy setting: the pharmacist’s role in identifying and addressing risk of substance use disorder, J. Addict. Med., 13, 403, 10.1097/ADM.0000000000000525 · DOI
  63. Starrels, 2010, Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain, Ann. Intern. Med., 152, 712, 10.7326/0003-4819-152-11-201006010-00004 · DOI · Paper page
  64. Thomas, 2014, Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts, Pharmacoepidemiol. Drug Saf., 23, 950, 10.1002/pds.3666 · DOI
  65. Thornton, 2020, Differences between pharmacists’ perception of counseling and practice in the era of prescription drug misuse, Pharm. Pract., 18, 1682
  66. Wang, 2015, Pediatric emergency physician knowledge of prescription drug monitoring programs and interpretation of prescription profiles, Acad. Emerge. Med., 1, S233
  67. Weiner, 2013, Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department, Ann. Emerg. Med., 62, 281, 10.1016/j.annemergmed.2013.05.025 · DOI
  68. Wilson, 2019, Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review, J. Pain, 20, 1383, 10.1016/j.jpain.2019.04.007 · DOI
  69. Winstanley, 2018, Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing, Drug Alcohol Depend., 188, 169, 10.1016/j.drugalcdep.2018.03.036 · DOI
  70. Worley, 2015, Psychiatric prescribers’ experiences with doctor shoppers, J. Am. Psychiatr. Nurses Assoc., 21, 309, 10.1177/1078390315612262 · doi:10.1177/1078390315612262
  71. Young, 2017, The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida, Int. J. Emerg. Med., 10, 1, 10.1186/s12245-017-0140-0 · DOI

Cited by

See all 45

Metadata

Authors
Picco, L., Lam, T., Haines, S., & Nielsen, S.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2021-11
Volume
228
Pages
109090
ISSN
0376-8716
DOI
10.1016/j.drugalcdep.2021.109090
Cited by
45
References
6
Language
en
Licence
Funders
National Health and Medical Research Council (1163961, 1189975)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2021.109090
The paper
Picco, L., Lam, T., Haines, S., & Nielsen, S. (2021). How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2021.109090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.